#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4902	16S	1529	1529	99.87	16S.l6.c4.ctg.1	2391	608.7	0	.	n	.	0	A922G	SNP	922	922	A	1368	1368	G	723	G,A,C	284,347,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4902	16S	1529	1529	99.87	16S.l6.c4.ctg.1	2391	608.7	0	.	n	.	0	C1450T	SNP	1450	1450	C	1896	1896	T	698	T	618	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4902	16S	1529	1529	99.87	16S.l6.c4.ctg.1	2391	608.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1630	1630	C	707	C	625	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7692	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3826	602.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1815	1815	A	713	A	620	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7692	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3826	602.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2449	2449	C	699	C	612	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7692	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3826	602.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2523	2523	A	729	A	637	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7692	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3826	602.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	3075	3075	C	671	C	592	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_U_01433c	folP.WHO_U_01433c	1	1	27	806	folP	852	852	99.88	folP.l15.c4.ctg.1	1932	125.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1752	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3748	140.2	1	SNP	p	S91F	0	.	.	271	273	TCC	803	805	TCC	178;177;178	T;C;C,G	155;157;155,1	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1752	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3748	140.2	1	SNP	p	D95G	0	.	.	283	285	GAC	815	817	GAC	173;174;175	G,A;A;C	154,1;152;156	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1752	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3748	140.2	1	SNP	p	D95N	0	.	.	283	285	GAC	815	817	GAC	173;174;175	G,A;A;C	154,1;152;156	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	710	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1650	129.0	0	.	p	.	0	A39T	NONSYN	115	117	GCC	602	604	ACC	183;183;185	A;C;C	160;159;160	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	710	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1650	129.0	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	800	802	CAC	199;199;198	C;A;C	174;174;175	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	710	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1650	129.0	0	.	p	.	0	E117K	NONSYN	349	351	GAA	836	838	AAA	193;193;193	A;A;A	173;173;174	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	710	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1650	129.0	1	SNP	p	G45D	0	.	.	133	135	GGC	620	622	GGC	184;185;186	G;G;C	164;161;162	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	466	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1276	109.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1644	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3326	148.3	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1641	1643	ATC	223;223;223	A;T;C	189;187;189	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1644	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3326	148.3	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1794	1796	GCA	246;244;243	G;C;A	209;206;202	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1644	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3326	148.3	0	.	p	.	0	V596I	NONSYN	1786	1788	GTT	2277	2279	ATT	170;168;167	A;T;T	148;148;148	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1644	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3326	148.3	1	SNP	p	D86N	0	.	.	256	258	GAC	747	749	GAC	194;194;194	G;A,G;C	169;164,1;168	parC.WHO_F_01444:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1644	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3326	148.3	1	SNP	p	S87I	0	.	.	259	261	AGT	750	752	AGT	195;196;196	A;G;T	167;171;169	parC.WHO_F_01444:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1644	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3326	148.3	1	SNP	p	S87W	0	.	.	259	261	AGT	750	752	AGT	195;196;196	A;G;T	167;171;169	parC.WHO_F_01444:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1644	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3326	148.3	1	SNP	p	S87R	0	.	.	259	261	AGT	750	752	AGT	195;196;196	A;G;T	167;171;169	parC.WHO_F_01444:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1644	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3326	148.3	1	SNP	p	S88P	0	.	.	262	264	TCC	753	755	TCC	197;195;196	T;C;C,G	169;166;168,1	parC.WHO_F_01444:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1450	parE	1986	1986	99.9	parE.l15.c4.ctg.1	2979	146.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1708	1710	GGC	194;192;193	G;G;C	167;167;168	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.002	penA.22.002	1	1	27	1356	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2632	154.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1298	1300	GCA	210;210;209	G;C;A	176;178;178	penA.22.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	1356	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2632	154.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1301	1303	ATC	209;209;209	A;T;C	180;180;180	penA.22.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	1356	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2632	154.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1313	1315	GTG	206;204;204	G;T;G	181;178;178	penA.22.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	1356	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2632	154.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1313	1315	GTG	206;204;204	G;T;G	181;178;178	penA.22.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	1356	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2632	154.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1817	1819	ACC	177;177;177	A;C;C	161;160;157	penA.22.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	1356	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2632	154.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1871	1873	GCG	174;173;174	G;C;G	147;135;135	penA.22.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	1356	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2632	154.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1871	1873	GCG	174;173;174	G;C;G	147;135;135	penA.22.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	1356	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2632	154.1	1	SNP	p	G543S	0	.	.	1627	1629	GGT	1994	1996	GGT	168;167;167	G;G;T	136;142;141	penA.22.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	1356	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2632	154.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2003	2005	GGC	166;165;164	G,T;G;C	136,1;139;139	penA.22.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	1356	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2632	154.1	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2021	2023	CCG	158;158;158	C,T;C;G	129,1;135;130	penA.22.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	1708	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3392	151.2	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1735	1737	CTG	178;178;179	C;T;G	145;145;152	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	852	porA	1146	1146	99.65	porA.l6.c4.ctg.1	2159	118.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	731	731	C	145	C	122	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	972	porB1b	1047	1047	99.14	porB1b.l6.c17.ctg.1	1990	143.9	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	919	921	CAA	196;195;196	C;A;A	171;171;174	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	972	porB1b	1047	1047	99.14	porB1b.l6.c17.ctg.1	1990	143.9	0	.	p	.	0	E212G	NONSYN	634	636	GAA	1126	1128	GGT	189;189;190	G;G;T	162;161;162	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	972	porB1b	1047	1047	99.14	porB1b.l6.c17.ctg.1	1990	143.9	0	.	p	.	0	H213D	NONSYN	637	639	CAT	1129	1131	GAT	190;190;191	G;A;T,C	162;163;162,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	972	porB1b	1047	1047	99.14	porB1b.l6.c17.ctg.1	1990	143.9	0	.	p	.	0	I218M	NONSYN	652	654	ATC	1144	1146	ATG	190;189;189	A;T;G,A	161;163;160,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	972	porB1b	1047	1047	99.14	porB1b.l6.c17.ctg.1	1990	143.9	0	.	p	.	0	R257K	NONSYN	769	771	AGG	1261	1263	AAG	184;185;184	A;A;G	156;156;160	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	972	porB1b	1047	1047	99.14	porB1b.l6.c17.ctg.1	1990	143.9	1	SNP	p	G120K	0	.	.	358	360	GGC	850	852	GGC	196;195;194	G;G;C,T	173;176;174,1	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	2930	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	5099	172.4	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2129	2131	CAT	158;157;157	C,A;A;T	139,1;137;140	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_F_02142c	rpsJ.WHO_F_02142c	1	1	27	462	rpsJ	312	312	100.0	rpsJ.l6.c30.ctg.1	1266	109.3	1	SNP	p	V57M	0	.	.	169	171	GTG	654	656	GTG	205;205;207	G;T;G	171;173;172	rpsJ.WHO_F_02142c:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
